Cargando…

UBE2T promotes proliferation via G2/M checkpoint in hepatocellular carcinoma

BACKGROUND: Growing evidence suggests that the ubiquitin-proteasome system is involved in the pathogenesis and recurrence of hepatocellular carcinoma (HCC); yet, little is known about the role of ubiquitin-conjugating enzyme E2T (UBE2T) in HCC. MATERIALS AND METHODS: UBE2T levels were detected in HC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Li-Li, Zhu, Ji-Min, Yu, Xiang-Nan, Zhu, Hai-Rong, Shi, Xuan, Bilegsaikhan, Enkhnaran, Guo, Hong-Ying, Wu, Jian, Shen, Xi-Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750879/ https://www.ncbi.nlm.nih.gov/pubmed/31571992 http://dx.doi.org/10.2147/CMAR.S202631

Ejemplares similares

Overexpressed pepsinogen C is associated with poor prognosis in human hepatocellular carcinoma: a tissue microarray study
por: Chen, Hong, et al.
Publicado: (2019)

UBE2M promotes cell proliferation via the β-catenin/cyclin D1 signaling in hepatocellular carcinoma
por: Zhang, Guang-Cong, et al.
Publicado: (2020)

Serum microRNA signatures and metabolomics have high diagnostic value in hepatocellular carcinoma
por: Liu, Hai-Ning, et al.
Publicado: (2017)

microRNA-106b-5p Promotes Cell Growth and Sensitizes Chemosensitivity to Sorafenib by Targeting the BTG3/Bcl-xL/p27 Signaling Pathway in Hepatocellular Carcinoma
por: Enkhnaran, Bilegsaikhan, et al.
Publicado: (2022)

Comprehensive analysis of long non-coding RNA-messenger RNA-microRNA co-expression network identifies cell cycle-related lncRNA in hepatocellular carcinoma
por: zhu, Hai-Rong, et al.
Publicado: (2019)

UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway
por: Shi, Zhan, et al.
Publicado: (2021)

UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop
por: Liu, Xu, et al.
Publicado: (2020)

UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway
por: Lu, Zi-Nan, et al.
Publicado: (2021)

Identification of UBE2T as an independent prognostic biomarker for gallbladder cancer
por: Zhu, Xuan, et al.
Publicado: (2020)

Identification of UBE2T as an independent prognostic biomarker for gallbladder cancer
por: Zhu, Xuan, et al.
Publicado: (2020)

UBE2C overexpression in melanoma and its essential role in G2/M transition
por: Liu, Guolong, et al.
Publicado: (2019)

UBE2S promotes cell chemoresistance through PTEN-AKT signaling in hepatocellular carcinoma
por: Gui, Liang, et al.
Publicado: (2021)

Ube2D3 and Ube2N are essential for RIG-I-mediated MAVS aggregation in antiviral innate immunity
por: Shi, Yuheng, et al.
Publicado: (2017)

UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation
por: Sun, Jingyuan, et al.
Publicado: (2020)

Contributions of UBE2C and UBE2S to meiotic progression of porcine oocytes
por: FUJIOKA, Yoshie A., et al.
Publicado: (2018)

UBE2S promotes the proliferation and survival of human lung adenocarcinoma cells
por: Liu, Zhi, et al.
Publicado: (2018)

UBE2T/STAT3 Signaling Promotes the Proliferation and Tumorigenesis in Retinoblastoma
por: Xu, Nuo, et al.
Publicado: (2022)

UBE2T silencing suppresses proliferation and induces cell cycle arrest and apoptosis in bladder cancer cells
por: Gong, Yan Qing, et al.
Publicado: (2016)

UBE2G1 governs the destruction of cereblon neomorphic substrates
por: Lu, Gang, et al.
Publicado: (2018)

Saikosaponin-d increases the radiosensitivity of smmc-7721 hepatocellular carcinoma cells by adjusting the g0/g1 and g2/m checkpoints of the cell cycle
por: Wang, Bao-Feng, et al.
Publicado: (2013)

Furosine Induced Apoptosis by the Regulation of STAT1/STAT2 and UBA7/UBE2L6 Genes in HepG2 Cells
por: Li, Huiying, et al.
Publicado: (2018)

UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma
por: Yang, Hao, et al.
Publicado: (2020)

UBE2T: A new molecular regulator of cancer stemness in hepatocellular carcinoma
por: Leung, Rainbow Wing Hei, et al.
Publicado: (2021)

Disorder of G2-M Checkpoint Control in Aniline-Induced Cell Proliferation in Rat Spleen
por: Wang, Jianling, et al.
Publicado: (2015)

SENP1 is a crucial promotor for hepatocellular carcinoma through deSUMOylation of UBE2T
por: Tao, Yifeng, et al.
Publicado: (2020)

Comprehensive analysis of UBE2C expression and its potential roles and mechanisms in hepatocellular carcinoma
por: Li, Xiao, et al.
Publicado: (2023)

Conformational Dynamics Modulate Activation of the Ubiquitin Conjugating Enzyme Ube2g2
por: Magala, Pearl, et al.
Publicado: (2017)

The diagnostic and prognostic value of UBE2T in intrahepatic cholangiocarcinoma
por: Yu, Hua, et al.
Publicado: (2020)

The landscape of UBE2S in hepatocellular carcinoma: Prognostic significance, immuno-oncology feature and drug response
por: Qiu, Lipeng, et al.
Publicado: (2022)

DNA primase subunit 1 deteriorated progression of hepatocellular carcinoma by activating AKT/mTOR signaling and UBE2C-mediated P53 ubiquitination
por: Zhu, Mengqi, et al.
Publicado: (2021)

UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism
por: Zhu, Zhenru, et al.
Publicado: (2022)

Identification of the potential therapeutic target gene UBE2C in human hepatocellular carcinoma: An investigation based on GEO and TCGA databases
por: Wei, Zilun, et al.
Publicado: (2019)

UBE2C functions as a potential oncogene by enhancing cell proliferation, migration, invasion, and drug resistance in hepatocellular carcinoma cells
por: Xiong, Yu, et al.
Publicado: (2019)

Circular RNA circUBE2J2 acts as the sponge of microRNA-370-5P to suppress hepatocellular carcinoma progression
por: Zhang, Lu, et al.
Publicado: (2021)

LncRNA CASC11 Promotes Hepatocellular Carcinoma Progression via Upregulation of UBE2T in a m(6)A-Dependent Manner
por: Chen, Fei, et al.
Publicado: (2021)

Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression
por: Ren, Xiaoyue, et al.
Publicado: (2021)

Diverse roles of UBE2T in cancer (Review)
por: Ma, Nengqian, et al.
Publicado: (2023)

UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma
por: Hao, Peng, et al.
Publicado: (2019)

Mechanism and disease association of E2-conjugating enzymes: lessons from UBE2T and UBE2L3
por: Alpi, Arno F., et al.
Publicado: (2016)

UBE2J2 promotes hepatocellular carcinoma cell epithelial-mesenchymal transition and invasion in vitro
por: Chen, Shaopeng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lhad05oq09llltonqdc2nhn4ue